Recent whole-genome sequencing revealed that mutations in TP53 and its related molecules, such as CTNNB1, AXIN1, and BRD7, define core pathways that are commonly deregulated in HCC (16). This evidence concerns the gene CTNNB1 and hepatocellular carcinoma.